LEUKEMIA RES 2021 10.1016/j.leukres.2021.106578

Treatment-free remission of chronic myeloid leukemia in real-world practice by the detection limit of MR4.3

Park¹, S; Choi, EJ; Lee, H; Jo, DY; Jung, CW; Kong, JH; Kim, H

J CLIN MED 2021 10.3390/jcm10071376

Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?

Jung¹, J; Jhun, BW; Jeong, M; Yoon, SJ; Huh, HJ; Jung, CW; Kim, K; Park, JB; Kim, DJ; Huh, W; Jang, HR; Kim, YH; Hong, SN; Chung, DR; Kang, ES

SCI REP-UK 2021 10.1038/s41598-021-88449-4

Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients

Shin¹, SY; Lee, H; Lee, ST; Choi, JR; Jung, CW; Koo, HH; Kim, SH

KOREAN J INTERN MED 2021 10.3904/kjim.2019.385

Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome

Jung¹, HA; Jung, CW; Jang, JH

KOREAN J INTERN MED 2021 10.3904/kjim.2020.319

The 2020 revision of the guidelines for the management of myeloproliferative neoplasms

Kim¹, SY; Bae, SH; Bang, SM; Eom, KS; Hong, J; Jang, S; Jung, CW; Kim, HJ; Kim, HY; Kim, MK; Kim, SJ; Mun, YC; Nam, SH; Park, J; Won, JH; Choi, CW

KOREAN J INTERN MED 2021 10.3904/kjim.2019.210

Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study

Choi¹, Y; Lee, JH; Jung, CW; Jo, JC; Kim, JS; Kim, I; Park, S; Cheong, JW; Park, SH; Kim, SY; Lee, HG

SUPPORT CARE CANCER 2020 10.1007/s00520-020-05884-1

Association between body image dissatisfaction and poor quality of life and depression among patients with hematopoietic stem cell transplantation

Kang¹, D; Kim, IR; Choi, HJ; Jung, CW; Yoon, SS; Kim, JS; Lee, CH; Jang, JH; Cho, J

TRANSPL INFECT DIS 2020 10.1111/tid.13482

A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia

Yang¹, J; Moon, S; Kwon, M; Huh, K; Jung, CW

SCI REP-UK 2020 10.1038/s41598-020-71386-z

Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia

Kim¹, B; Yun, W; Lee, ST; Choi, JR; Yoo, KH; Koo, HH; Jung, CW; Kim, SH

PATIENT EDUC COUNS 2020 10.1016/j.pec.2020.03.007

Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partners

Kim¹, IR; Jang, SY; Shin, HS; Choi, HJ; Jung, CW; Yoon, SS; Kim, JS; Kim, SJ; Kim, K; Kim, WS; Lee, CH; Kang, D; Cho, J

TRANSPLANTATION 2020 10.1097/TP.0000000000003006

Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation Protocol Optimization

Lee¹, KW; Park, JB; Park, H; Kwon, Y; Lee, JS; Kim, KS; Chung, YJ; Rhu, JS; Choi, S; Kwon, GY; Kim, HJ; Kang, ES; Jung, CW; Shin, EC; Kawai, T; Kim, SJ; Joh, JW

J CLIN MED 2020 10.3390/jcm9072310

Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia

Byun¹, JM; Hong, J; Oh, D; Yhim, HY; Do, YR; Park, JS; Jung, CW; Yang, DH; Won, JH; Lee, HG; Moon, JH; Mun, YC; Jo, DY; Han, JJ; Lee, JH; Lee, JH; Lee, J; Yoon, SS

BLOOD ADV 2020 10.1182/bloodadvances.2019000757

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Lee¹, JH; Faderl, S; Pagel, JM; Jung, CW; Yoon, SS; Pardanani, AD; Becker, PS; Lee, H; Choi, J; Lee, K; Kim, M; Cortes, JE

BRIT J HAEMATOL 2020 10.1111/bjh.16599

TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries

Turkina¹, A; Wang, JX; Mathews, V; Saydam, G; Jung, CW; Al Hashmi, HH; Yassin, M; Le Clanche, S; Miljkovic, D; Slader, C; Hughes, TP

ANN LAB MED 2020 10.3343/alm.2020.40.1.88

Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults

Choi¹, S; Kim, YJ; Yoo, KH; Sung, KW; Koo, HH; Kim, SJ; Jang, JH; Kim, K; Jung, CW; Huh, HJ; Kang, ES

MYCOSES 2020 10.1111/myc.13020

Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level

Oh¹, J; Kang, CI; Kim, SH; Huh, K; Cho, SY; Chung, DR; Lee, SY; Jung, CW; Peck, KR

MOL BIOL REP 2019 10.1007/s11033-019-05019-8

Anti-leukemic effects of simvastatin on NRAS(G12D) mutant acute myeloid leukemia cells

Jang¹, J; Lee, J; Jang, JH; Jung, CW; Park, S

INT J HEMATOL 2019 10.1007/s12185-019-02749-0

Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia

Fujishima¹, N; Uchida, T; Onishi, Y; Jung, CW; Goh, YT; Ando, K; Wang, MC; Ono, C; Matsumizu, M; Paccagnella, ML; Sleight, B; Vandendries, E; Fujii, Y; Hino, M

GENE CHROMOSOME CANC 2019 10.1002/gcc.22825

Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement

Yoon¹, J; Yun, JW; Jung, CW; Ju, HY; Koo, HH; Kim, SH; Kim, HJ

J CLIN LAB ANAL 2019 10.1002/jcla.23064

Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia

Yun¹, JW; Yoon, J; Jung, CW; Lee, KO; Kim, JW; Kim, SH; Kim, HJ

Lancet Haematol 2019 10.1016/S2352-3026(19)30153-X

Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial

Lee¹, JW; Lee, SE; Jung, CW; Park, S; Keta, H; Park, SK; Kim, JA; Oh, IH; Jang, JH

J CLIN LAB ANAL 2019 10.1002/jcla.22951

Clonal dominance of a donor-derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q)

Yoon¹, J; Yun, JW; Jung, CW; Kim, HJ; Kim, SH

BONE MARROW TRANSPL 2019 10.1038/s41409-019-0492-6

Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD)

Yoon¹, JH; Yoo, KH; Sung, KW; Jung, CW; Kim, JS; Hahn, SM; Kang, HJ; Lee, JH; Im, HJ; Ahn, JS; Kook, H; Cho, B; Lee, JW

LEUKEMIA 2019 10.1038/s41375-018-0321-8

HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia

Park¹, JH; Woo, YM; Youm, EM; Hamad, N; Won, HH; Naka, K; Park, EJ; Park, JH; Kim, HJ; Kim, SH; Kim, HJ; Ahn, JS; Sohn, SK; Moon, JH; Jung, CW; Park, S; Lipton, JH; Kimura, S; Kim, JW; Kim, D

ANN HEMATOL 2019 10.1007/s00277-019-03624-y

Different prognostic effects of core-binding factor positive AML with Korean AML registry data

Shin¹, HJ; Min, WS; Min, YH; Cheong, JW; Lee, JH; Kim, IH; Hong, DS; Ahn, JS; Kim, HJ; Lee, WS; Jung, CW; Jang, JH; Park, Y; Kim, HJ

HAEMATOL-HEMATOL J 2019 10.3324/haematol.2019.218487

Hereditary platelet function disorder from RASGRP2 gene mutations encoding CalDAG-GEFI identified by whole-exome sequencing in a Korean woman with severe bleeding

Yun¹, JW; Lee, KO; Jung, CW; Oh, SY; Kim, SH; Choi, CW; Kim, HJ

J CLIN MICROBIOL 2018 10.1128/JCM.00438-18

Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients

Ryu¹, MR; Park, MS; Cho, EH; Jung, CW; Kim, K; Kim, SJ; Oh, HY; Huh, W; Jang, HR; Koh, WJ; Park, HY; Kim, YH; Sinn, DH; Choi, JO; Joh, JW; Kim, JM; Kim, SJ; Park, JB; Kang, ES

ANN LAB MED 2018 10.3343/alm.2018.38.6.495

Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia

Kim¹, HY; Lee, KO; Park, S; Jang, JH; Jung, CW; Kim, SH; Kim, HJ

BONE MARROW TRANSPL 2018 10.1038/s41409-018-0097-5

Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study

Yoo¹, KH; Kang, D; Kim, IR; Choi, EK; Kim, JS; Yoon, SS; Lee, CH; Park, S; Kim, SJ; Kim, K; Kim, WS; Jung, CW; Choi, HJ; Jang, JH; Cho, J

ANN HEMATOL 2018 10.1007/s00277-018-3260-6

Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients

Park¹, S; Choi, H; Kim, HJ; Ahn, JS; Kim, HJ; Kim, SH; Mun, YC; Jung, CW; Kim, D

Cancer Med 2018 10.1002/cam4.1450

A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea

Shin¹, J; Koh, Y; Yoon, SH; Cho, JY; Kim, DY; Lee, KH; Kim, HJ; Ahn, JS; Kim, YK; Park, J; Sohn, SK; Moon, JH; Lee, YJ; Yoon, S; Lee, JO; Cheong, JW; Ha Kim, K; Kim, SH; Kim, HG; Kim, H; Nam, SH; Do, YR; Park, SG; Park, SK; Bae, SH; Song, HH; Shin, DY; Oh, D; Kim, MK; Jung, CW; Park, S; Kim, I

ONCOTARGET 2018 10.18632/oncotarget.23575

Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype

Ahn¹, JS; Kim, HJ; Kim, YK; Lee, SS; Ahn, SY; Jung, SH; Yang, DH; Lee, JJ; Park, HJ; Lee, JY; Choi, SH; Jung, CW; Jang, JH; Kim, HJ; Moon, JH; Sohn, SK; Lee, YJ; Won, JH; Kim, SH; Zhang, ZL; Kim, T; Kim, DDH

CLIN CANCER RES 2017 10.1158/1078-0432.CCR-17-0957

Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Kwak¹, JY; Kim, SH; Oh, SJ; Zang, DY; Kim, H; Kim, JA; Do, YR; Kim, HJ; Park, JS; Choi, CW; Lee, WS; Mun, YC; Kong, JH; Chung, JS; Shin, HJ; Kim, DY; Park, J; Jung, CW; Bunworasate, U; Comia, NS; Jootar, S; Reksodiputro, AH; Caguioa, PB; Lee, SE; Kim, DW

KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2015.406

Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea

Kim¹, HS; Kim, HJ; Kim, SH; Choi, JY; Ko, YH; Kim, WS; Jung, CW; Kim, SJ

Nutrition. 2017 Apr;36:67-71. doi: 10.1016/j.nut.2016.06.009. Epub 2016 Jun 25.

Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma

Kim HS1¹, Lee JY2, Lim SH2, Cho J3, Kim SJ2, Jang JH2, Kim WS2, Jung CW2, Kim K4.

Oncotarget. 2017 Jan 31;8(5):8305-8314. doi: 10.18632/oncotarget.14171.

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

Ahn JS1¹,2, Kim HJ1,2, Kim YK1,2, Lee SS1, Ahn SY1, Jung SH1, Yang DH1, Lee JJ1, Park HJ2, Choi SH2, Jung CW3, Jang JH3, Kim HJ4, Moon JH5, Sohn SK5, Won JH6, Kim SH7, Michael S8, Minden MD9, Kim DD9.

Ann Hematol. 2016 Mar;95(4):625-35. doi: 10.1007/s00277-015-2580-z. Epub 2015 Dec 22.

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML

Ahn JS1¹, Kim HJ2, Kim YK1, Jung SH1, Yang DH1, Lee JJ1, Kim NY3, Choi SH3, Jung CW4, Jang JH4, Kim HJ5, Moon JH6, Sohn SK6, Won JH7, Kim SH8, Kim DD9.

J Transl Med. 2016 Mar 24;14:82. doi: 10.1186/s12967-016-0837-5.

Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia

Zheng Q1¹,2, Cao J3, Hamad N4,5, Kim HJ6, Moon JH7, Sohn SK7, Jung CW8, Lipton JH4,5, Kim DD4,5.

J Clin Lab Anal. 2016 Nov;30(6):1061-1070. doi: 10.1002/jcla.21981. Epub 2016 May 2.

Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patients

Yoo EH1¹, Park KJ2,3, Won HH2,3, Park JH2,3, Park JH2,3, Lee ST4, Kim HJ4, Bang SM5, Chi HS6, Jung CW7, Kim SH4, Yun H8, Sun CH8, Park I8, Lee S8, Lee C9, Merriman B9, Luo R10, Tan EH10, Park KJ11, Yoo NK11, Kang JJ9, Kim JW12.

J Infect. 2016 Nov;73(5):496-505. doi: 10.1016/j.jinf.2016.06.011. Epub 2016 Jul 7.

Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients

Park S1¹, Kim K1, Jang JH1, Kim SJ1, Kim WS1, Chung DR2, Kang CI2, Peck KR2, Jung CW3.

Biol Blood Marrow Transplant. 2016 Jan;22(1):61-70. doi: 10.1016/j.bbmt.2015.07.030. Epub 2015 Jul 31.

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

Ahn JS1¹, Kim HJ2, Kim YK1, Lee SS1, Jung SH1, Yang DH1, Lee JJ1, Kim NY3, Choi SH3, Jung CW4, Jang JH4, Kim HJ5, Moon JH6, Sohn SK6, Won JH7, Kim SH8, Kim DD9.

Ann Hematol. 2016 Jan;95(2):325-35. doi: 10.1007/s00277-015-2523-8. Epub 2015 Oct 10.

Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis

Lim SH1¹, Park S1, Jang JH1, Kim K1, Kim HJ2, Kim SH2, Kang CI3, Chung DR3, Peck KR3, Lee J4, Cha HS4, Koh EM4, Ko YH5, Kim WS1, Jung CW1, Kim SJ6,7.

Ann Hematol. 2016 Jan;95(2):301-10. doi: 10.1007/s00277-015-2540-7. Epub 2015 Nov 4.

Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant

Ahn JS1¹, Kim JY1, Kim HJ2, Kim YK1, Lee SS1, Jung SH1, Yang DH1, Lee JJ1, Kim NY3, Choi SH3, Minden MD4, Jung CW5, Jang JH5, Kim HJ6, Moon JH7, Sohn SK7, Won JH8, Kim SH9, Kim DD4.

Oncotarget. 2016 Sep 13;7(37):59892-59901. doi: 10.18632/oncotarget.10988.

Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation

Park S1¹, Kim K1, Jang JH1, Kim SJ1, Kim WS1, Jung CW1.

Ann Hematol. 2016 Aug;95(8):1223-32. doi: 10.1007/s00277-016-2691-1. Epub 2016 May 26.

Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study

Byun JM1¹, Kim YJ2, Yoon HJ3, Kim SY3, Kim HJ4, Yoon J4, Min YH5, Cheong JW5, Park J6, Lee JH6, Hong DS7, Park SK7, Kim HJ8, Ahn JS8, Shin HJ9, Chung JS9, Lee WS10, Lee SM10, Park Y11, Kim BS11, Lee JH12, Lee KH12, Jung CW13, Jang JH13, Min WS14, Park TS15; AML/MDS working party of Korean Society of Hematology.

Oncotarget. 2016 Aug 23;7(34):54825-54837. doi: 10.18632/oncotarget.10240.

Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations

Shin SY1¹, Lee ST2, Kim HJ3, Cho EH4, Kim JW3, Park S5, Jung CW5, Kim SH3.

J Clin Pathol. 2016 Aug;69(8):737-41. doi: 10.1136/jclinpath-2016-203649. Epub 2016 May 19.

High frequency of JAK2 exon 12 mutations in Korean patients with polycythaemia vera: novel mutations and clinical significance

Park CH1¹, Lee KO2, Jang JH3, Jung CW3, Kim JW1, Kim SH1, Kim HJ1.

Hum Immunol. 2015 Sep;76(9):636-43. doi: 10.1016/j.humimm.2015.09.009. Epub 2015 Sep 25.

KIR alloreactivity based on the receptor-ligand model is associated with improved clinical outcomes of allogeneic hematopoietic stem cell transplantation: Result of single center prospective study

Park S1¹, Kim K1, Jang JH1, Kim SJ1, Kim WS1, Kang ES2, Jung CW3.

Haematologica. 2015 Sep;100(9):e351-3. doi: 10.3324/haematol.2015.126227. Epub 2015 Jun 4.

Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype

Ahn JS1¹, Kim HJ2, Kim YK1, Jung SH1, Yang DH1, Lee JJ1, Lee IK3, Kim NY3, Minden MD4, Jung CW5, Jang JH5, Kim HJ6, Moon JH7, Sohn SK7, Won JH8, Kim SH9, Kim N10, Yoshida K11, Ogawa S11, Kim DD4.

Oncotarget. 2015 Dec 15;6(40):42803-12. doi: 10.18632/oncotarget.5658.

Iron deficient erythropoiesis might play key role in development of anemia in cancer patients

Park S1¹, Jung CW1, Kim K1, Kim SJ1, Kim WS1, Jang JH1.

Am J Hematol. 2015 Nov;90(11):1013-20. doi: 10.1002/ajh.24137. Epub 2015 Oct 12.

Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Lim SN1¹, Joo YD1, Lee KH2, Kim DY2, Lee JH2, Lee JH2, Chi HS3, Yun SC4, Lee WS5, Lee SM5, Park S6, Kim I6, Sohn SK7, Moon JH7, Ryoo HM8, Bae SH8, Hyun MS9, Kim MK9, Kim HJ10, Yang DH10, Eom HS11, Lee GW12, Jung CW13, Won JH14, Kim H15, Lee JH16, Shin HJ17, Jang DY18.

Liver Int. 2015 Nov;35(11):2363-9. doi: 10.1111/liv.12838. Epub 2015 Apr 12.

Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy

Lee JY1¹, Lim SH1, Lee MY1, Kim H1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Jung CW1, Jang JH1, Kim WS1, Kim SJ1, Kim K1.

Korean J Intern Med. 2015 Nov;30(6):771-88. doi: 10.3904/kjim.2015.30.6.771. Epub 2015 Oct 30.

Guidelines for the management of myeloproliferative neoplasms

Choi CW1¹, Bang SM2, Jang S3, Jung CW4, Kim HJ5, Kim HY6, Kim SJ7, Kim YK8, Park J9, Won JH10.

Blood Cancer J. 2015 Oct 16;5:e358. doi: 10.1038/bcj.2015.84.

Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype

Jang JE1¹, Min YH1, Yoon J2, Kim I3, Lee JH4, Jung CW5, Shin HJ6, Lee WS7, Lee JH8, Hong DS9, Kim HJ10, Kim HJ2, Park S3, Lee KH4, Jang JH5, Chung JS6, Lee SM7, Park J8, Park SK9, Ahn JS10, Min WS2, Cheong JW1; Korean Society of Hematology AML/MDS Working Party.

Transpl Infect Dis. 2015 Oct;17(5):679-87. doi: 10.1111/tid.12424. Epub 2015 Sep 26.

Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma

Park S1¹, Jung CW1, Jang JH1, Kim SJ1, Kim WS1, Kim K1.

Blood. 2015 Aug 6;126(6):746-56. doi: 10.1182/blood-2015-03-636548. Epub 2015 Jun 11.

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Kim DY¹, Joo YD, Lim SN, Kim SD, Lee JH, Lee JH, Kim DH, Kim K, Jung CW, Kim I, Yoon SS, Park S, Ahn JS, Yang DH, Lee JJ, Lee HS, Kim YS, Mun YC, Kim H, Park JH, Moon JH, Sohn SK, Lee SM, Lee WS, Kim KH, Won JH, Hyun MS, Park J, Lee JH, Shin HJ, Chung JS, Lee H, Eom HS, Lee GW, Cho YU, Jang S, Park CJ, Chi HS, Lee KH; Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology.

Eur J Clin Microbiol Infect Dis. 2015 Jul;34(7):1437-41. doi: 10.1007/s10096-015-2370-5. Epub 2015 Apr 17.

Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study

Ko JH1¹, Peck KR, Lee WJ, Lee JY, Cho SY, Ha YE, Kang CI, Chung DR, Jung CW, Kang ES, Song JH.

Leuk Lymphoma. 2015 Jul;56(7):2067-74. doi: 10.3109/10428194.2014.969260. Epub 2014 Nov 20.

Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis

Jung CW1¹, Shih LY, Xiao Z, Jie J, Hou HA, Du X, Wang MC, Park S, Eom KS, Oritani K, Okamoto S, Tauchi T, Kim JS, Zhou D, Saito S, Li J, Handa H, Jianyong L, Ohishi K, Hou M, Depei W, Takenaka K, Liu T, Hu Y, Amagasaki T, Ito K, Gopalakrishna P, Akashi K.

Oncotarget. 2015 Jun 30;6(18):16653-62.

Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients

Jung HA1¹,2, Maeng CH3, Kim M1, Kim S1, Jung CW1, Jang JH1.

Acta Haematol. 2015;134(1):40-8. doi: 10.1159/000368711. Epub 2015 Jun 6.

Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome

Ahn JS1¹, Kim YK, Min YH, Cheong JW, Jang JH, Jung CW, Kim IH, Yoon HJ, Lee HG, Sohn SK, Moon JH, Kim H, Kim YJ, Won JH, Chung JS, Mun YC, Lee JH, Kim HJ.

Leuk Lymphoma. 2015 May;56(5):1550-1. doi: 10.3109/10428194.2014.971408. Epub 2014 Nov 3.

A case of CD5-positive mature B-cell neoplasm with t(10;14)(q24;q11.2) and trisomy 12

Shin SY1¹, Lee ST, Kim HJ, Jang JH, Jung CW, Kim SH.

Anticancer Res. 2015 May;35(5):3081-9.

Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome

Hong JY1¹, Seo JY2, Kim SH3, Jung HA4, Park S4, Kim K4, Jung CW4, Kim JS5, Park JS6, Kim HJ7, Jang JH8.

Ann Lab Med. 2015 Mar;35(2):257-9. doi: 10.3343/alm.2015.35.2.257. Epub 2015 Feb 12.

BRAF V600E and MAP2K1 Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma Cases

Shin SY1¹, Lee ST1, Kim HJ1, Ki CS1, Jung CW2, Kim JW1, Kim SH1.

Platelets. 2015;26(1):38-42. doi: 10.3109/09537104.2013.869312. Epub 2014 Jan 16.

Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura

Kim WH1¹, Park JB, Jung CW, Kim GS.

Anticancer Res. 2014 Aug;34(8):4299-306.

Renal Insufficiency in Newly-diagnosed Multiple Myeloma: Analysis According to International Myeloma Working Group Consensus Statement

Park S1¹, Han B2, Kim K3, Kim SJ1, Jang JH1, Kim WS1, Jung CW1.

Biomed Res Int. 2014;2014:437852. doi: 10.1155/2014/437852. Epub 2014 Jul 10.

Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma

Kim SM1¹, Kim MJ1, Jung HA1, Kim K1, Kim SJ1, Jang JH1, Kim WS1, Jung CW1.

Ann Hematol. 2014 Jun;93(6):931-5. doi: 10.1007/s00277-014-2006-3. Epub 2014 Jan 31.

Hereditary gene mutations in Korean patients with isolated erythrocytosis

Jang JH1¹, Seo JY, Jang J, Jung CW, Lee KO, Kim SH, Kim HJ.

Acta Haematol. 2014;131(4):193-9. doi: 10.1159/000354839. Epub 2013 Nov 26.

Positive Correlation between Baseline PET or PET/CT Findings and Clinical Parameters in Multiple Myeloma Patients

Park S1¹, Lee SJ, Chang WJ, Maeng CH, Hong JY, Choi MK, Kim YS, Jung CW, Jang JH, Kim SJ, Kim WS, Choi JY, Kim K.

Ann Hematol. 2014 May;93(5):877-8. doi: 10.1007/s00277-013-1903-1. Epub 2013 Sep 17.

A unique case of dendritic cell neoplasm from monocyte-derived myeloid origin with distinct immunophenotype and cytomorphology

Jang MA1¹, Lee ST, Jung CW, Kim SH.

Ann Hematol. 2014 Apr;93(4):603-8. doi: 10.1007/s00277-013-1915-x. Epub 2013 Oct 19.

Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia/myeloproliferative neoplasms with ring sideroblasts

Seo JY1¹, Lee KO, Kim SH, Kim K, Jung CW, Jang JH, Kim HJ.

Haematologica. 2014 Mar;99(3):561-9. doi: 10.3324/haematol.2013.092023. Epub 2013 Oct 25.

Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population

Kim HJ1¹, Seo JY, Lee KO, Bang SH, Lee ST, Ki CS, Kim JW, Jung CW, Kim DK, Kim SH.

Vox Sang. 2014 Nov;107(4):407-15. doi: 10.1111/vox.12183. Epub 2014 Jul 31.

Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience

Lee KH1¹, Jung SK, Kim SJ, Jang JH, Kim K, Kim WS, Jung CW, Kim DW, Kang ES.

Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1847-53. doi: 10.1007/s10096-014-2107-x. Epub 2014 May 23.

Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer

Ko JH1¹, Peck KR, Lee WJ, Huh K, Yoo JR, Kim K, Cho SY, Ha YE, Kang CI, Chung DR, Jung CW, Kim YH, Lee NY, Kim KM, Song JH.

Leuk Lymphoma. 2014 Oct;55(10):2395-7. doi: 10.3109/10428194.2014.880429. Epub 2014 Mar 7.

Spinal cord compression in multiple myeloma: a single center experience

Jung HA1¹, Cho SH, Kim SJ, Jang JH, Kim WS, Jung CW, Kim K.

Acta Haematol. 2014;131(1):18-27. doi: 10.1159/000351060. Epub 2013 Sep 10.

Clinical Features and Treatment Outcomes of Intravascular Large B-Cell Lymphoma: A Single-Center Experience in Korea

Hong JY1¹, Kim HJ, Ko YH, Choi JY, Jung CW, Kim SJ, Kim WS.

Ann Hematol. 2014 Jan;93(1):99-105. doi: 10.1007/s00277-013-1952-5. Epub 2013 Nov 16.

DCEP for relapsed or refractory multiple myeloma after therapy with novel agents

Park S1¹, Lee SJ, Jung CW, Jang JH, Kim SJ, Kim WS, Kim K.

Leuk Res. 2014 Jul;38(7):730-6. doi: 10.1016/j.leukres.2014.01.002. Epub 2014 Jan 10.

Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: Fludarabine versus cyclophosphamide-ATG

Kim H1¹, Lee KH2, Kim I3, Sohn SK4, Jung CW5, Joo YD6, Kim SH7, Kim BS8, Choi JH9, Kwak JY10, Kim MK11, Bae SH12, Shin HJ13, Won JH14, Lee WS15, Oh S16, Kim HJ17, Park JH18; Korean Society of Blood and Marrow Transplantation.

J Thromb Haemost. 2014 Jul;12(7):1035-43. doi: 10.1111/jth.12611. Epub 2014 Jun 27.

Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database

Yhim HY1¹, Jang MJ, Bang SM, Kim KH, Kim YK, Nam SH, Bae SH, Kim SH, Mun YC, Kim I, Jung CW, Oh D.

Transfusion. 2014 Jun;54(6):1542-51. doi: 10.1111/trf.12507. Epub 2013 Dec 3.

Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia

Cheong JW1¹, Kim HJ, Lee KH, Yoon SS, Lee JH, Park HS, Kim HY, Shim H, Seong CM, Kim CS, Chung J, Hyun MS, Jo DY, Jung CW, Sohn SK, Yoon HJ, Kim BS, Joo YD, Park CY, Min YH; Korean Society of Hematology Acute Myeloid Leukemia/Myelodysplastic Syndrome Working Party.

Int J Hematol. 2014;99(5):635-43. doi: 10.1007/s12185-014-1549-3. Epub 2014 Mar 20.

Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes

Kim Y1¹, Kim IH, Kim HJ, Park S, Lee KH, Kim SJ, Lee JH, Kim DY, Yoon SS, Kim YK, Jang JH, Park SY, Ahn JS, Cheong CW, Lee JH, Cheong JW; Korean Society of Hematology Acute myeloid Leukemia/Myelodysplastic Syndrome Working Party.

Anticancer Res. 2014 Feb;34(2):1037-45.

Prognostic Factor Analysis in Core-Binding Factor-positive Acute Myeloid Leukemia

Jung HA1¹, Maeng CH, Park S, Kim SJ, Kim K, Jang JH, Jung CW.

J Korean Med Sci. 2014 Feb;29(2):164-71. doi: 10.3346/jkms.2014.29.2.164. Epub 2014 Jan 28.

Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines

Bang SM1¹, Jang MJ2, Kim KH3, Yhim HY4, Kim YK5, Nam SH6, Hwang HG7, Bae SH8, Kim SH9, Mun YC10, Kim YK3, Kim I11, Choi WI12, Jung CW13, Park NH14, Choi NK14, Park BJ15, Oh D2, Korean Society of Thrombosis and Hemostasis.

Leuk Res. 2013 Oct;37(10):1241-7. doi: 10.1016/j.leukres.2013.06.024. Epub 2013 Jul 18.

Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia

Kim H1¹, Lee KH, Sohn SK, Jung CW, Joo YD, Kim SH, Kim BS, Choi JH, Kwak JY, Kim MK, Bae SH, Shin HJ, Won JH, Oh S, Lee WS, Park JH, Yoon SS.

Br J Haematol. 2013 Oct;163(1):62-71. doi: 10.1111/bjh.12492.

Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype

Choi H¹, Jung C, Sohn SK, Kim S, Kim HJ, Kim YK, Kim T, Zhang Z, Shin ES, Lee JE, Moon JH, Kim SH, Kim KH, Mun YC, Kim H, Park J, Kim J, Kim D.

Ann Hematol. 2013 Aug;92(8):1101-10. doi: 10.1007/s00277-013-1728-y. Epub 2013 Apr 5.

Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia

Lee SM1¹, Lee WS, Shin HJ, Lee JJ, Sohn SK, Moon JH, Eom HS, Won JH, Lee KH, Lee JH, Kim DY, Yoon SS, Kim I, Jung CW, Kim SJ, Kim H, Lee JH, Ryoo HM, Lee GW, Kim SH, Mun YC, Kim MK, Joo YD; Korean Society of Hematology Adult ALL working party.

Ann Oncol. 2013 Mar;24(3):756-60. doi: 10.1093/annonc/mds532. Epub 2012 Oct 31.

Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients

Seong SJ1¹, Lim M, Sohn SK, Moon JH, Oh SJ, Kim BS, Ryoo HM, Chung JS, Joo YD, Bang SM, Jung CW, Kim DH, Park SY, Yoon SS, Kim I, Lee HG, Won JH, Min YH, Cheong JW, Park JS, Eom KS, Hyun MS, Kim MK, Kim H, Park MR, Park J, Kim CS, Kim HJ, Kim YK, Park EK, Zang DY, Jo DY, Lee HW, Yoon YR.

Int J Hematol. 2013 Mar;97(3):388-96. doi: 10.1007/s12185-013-1276-1. Epub 2013 Feb 9.

Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL)

Park S1¹, Lee SJ, Kim K, Jang JH, Kim DH, Lee KH, Lee JH, Lee JH, Kim DY, Jang DY, Kim H, Park JH, Ryoo HM, Bae SH, Kim MK, Hyun MS, Joo YD, Lee WS, Lee SM, Jung CW.

Genes Chromosomes Cancer. 2013 Jan;52(1):44-55. doi: 10.1002/gcc.22005. Epub 2012 Sep 28.

Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category

Huh J1¹, Jung CW, Kim HJ, Kim YK, Moon JH, Sohn SK, Kim HJ, Min WS, Kim DH.

Ann Hematol. 2013 Jan;92(2):163-71. doi: 10.1007/s00277-012-1580-5. Epub 2012 Sep 28.

KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement

Kim HJ1¹, Ahn HK, Jung CW, Moon JH, Park CH, Lee KO, Kim SH, Kim YK, Kim HJ, Sohn SK, Kim SH, Lee WS, Kim KH, Mun YC, Kim H, Park J, Min WS, Kim HJ, Kim DH; L/MDS working party, Korean Society of Hematology.

Am J Hematol. 2012 Oct;87(10):961-8. doi: 10.1002/ajh.23281. Epub 2012 Aug 7.

A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia

Huh J1¹, Kim HJ, Jung CW, Kim HJ, Kim SH, Kim YK, Kim HJ, Shin MG, Moon JH, Sohn SK, Kim SH, Lee WS, Won JH, Mun YC, Kim H, Park J, Min WS, Kim DH; AML/MDS working party, Korean Society of Hematology.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1500-8. doi: 10.1016/j.bbmt.2012.03.015. Epub 2012 Apr 1.

Allogeneic Hematopoietic Stem Cell Transplant for Adults over 40 Years Old with Acquired Aplastic Anemia

Kim H1¹, Lee KH, Yoon SS, Sohn SK, Joo YD, Kim SH, Kim BS, Choi JH, Kwak JY, Hyun MS, Bae SH, Shin HJ, Won JH, Oh S, Lee WS, Park JH, Jung CW; Korean Society of Blood and Marrow Transplantation.

Int J Hematol. 2012 Sep;96(3):327-33. doi: 10.1007/s12185-012-1142-6. Epub 2012 Jul 21.

Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia

Kong JH1¹, Mun YC, Kim S, Choi HS, Kim YK, Kim HJ, Moon JH, Sohn SK, Kim SH, Jung CW, Dennis Kim DH.

Med Oncol. 2012 Jun;29(2):1179-85. doi: 10.1007/s12032-011-9926-8. Epub 2011 Apr 7.

Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients

Moon JH1¹, Sohn SK, Kim SN, Park SY, Yoon SS, Kim IH, Kim HJ, Kim YK, Min YH, Cheong JW, Kim JS, Jung CW, Kim DH.

Am J Hematol. 2012 Jan;87(1):37-41. doi: 10.1002/ajh.22193. Epub 2011 Nov 25.

Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity

Ahn HK1¹, Jang JH, Kim K, Kim HJ, Kim SH, Jung CW, Kim DH.

J Clin Oncol. 2011 Dec 10;29(35):4702-8. doi: 10.1200/JCO.2011.35.5719. Epub 2011 Nov 14.

Adverse Prognostic Impact of Abnormal Lesions Detected by Genome-Wide Single Nucleotide Polymorphism Array-Based Karyotyping Analysis in Acute Myeloid Leukemia With Normal Karyotype

Yi JH1¹, Huh J, Kim HJ, Kim SH, Kim HJ, Kim YK, Sohn SK, Moon JH, Kim SH, Kim KH, Won JH, Mun YC, Kim H, Park J, Jung CW, Kim DH.

Leuk Lymphoma. 2011 Jun;52(6):1024-9. doi: 10.3109/10428194.2011.563885. Epub 2011 Apr 4.

Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia

Sohn SK1¹, Oh SJ, Kim BS, Ryoo HM, Chung JS, Joo YD, Bang SM, Jung CW, Kim DH, Yoon SS, Kim H, Lee HG, Won JH, Min YH, Cheong JW, Park JS, Eom KS, Hyun MS, Kim MK, Kim H, Park MR, Park J, Kim CS, Kim HJ, Kim YK, Park EK, Zang DY, Jo DY, Moon JH, Park SY.

Am J Hematol. 2011 Apr;86(4):346-50. doi: 10.1002/ajh.21980.

Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia

Lee SJ1¹, Jung CW, Kim DY, Lee KH, Sohn SK, Kwak JY, Kim HJ, Kim IH, Park S, Kim DH.

Int J Hematol. 2011 Mar;93(3):383-8. doi: 10.1007/s12185-011-0797-8. Epub 2011 Mar 1.

Retrospective analysis of paranasal sinusitis in patients receiving hematopoietic stem cell transplantation

Won YW1¹, Yi SY, Jang JH, Kim K, Kim SJ, Kim WS, Jung CW, Kim DH.

Int J Hematol. 2011 Feb;93(2):163-9. doi: 10.1007/s12185-011-0771-5. Epub 2011 Feb 3.

Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience

Jang MJ1¹, Chong SY, Kim IH, Kim JH, Jung CW, Kim JY, Park JC, Lee SM, Kim YK, Lee JE, Jang SS, Kim JS, Jo DY, Zang DY, Lee YY, Yhim HY, Oh D.

Diagnostic and therapeutic guideline for myeloproliferative neoplasm

Am J Hematol. 2010 Nov;85(11):856-62. doi: 10.1002/ajh.21850.

Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time-point does matter

Kim DH1¹, Sriharsha L, Jung CW, Kamel-Reid S, Radich JP, Lipton JH.

Ann Hematol. 2010 Jul;89(7):725-31. doi: 10.1007/s00277-010-0910-8. Epub 2010 Feb 24.

Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib

Koh Y1¹, Kim I, Yoon SS, Kim BK, Kim DY, Lee JH, Lee KH, Park E, Kim HJ, Sohn SK, Joo YD, Kim SJ, Chung J, Shin HJ, Kim SH, Kim CS, Song HS, Kim MK, Hyun MS, Ahn JS, Jung CW, Park S; Korean Society of Hematology CML working party.

Jpn J Clin Oncol. 2010 Jun;40(6):556-66. doi: 10.1093/jjco/hyq007. Epub 2010 Feb 25.

Re-analysis of the Outcomes of Post-Remission Therapy for Acute Myeloid Leukemia with Core Binding Factor According to Years of Patient Enrolment

Shin HJ1¹, Kim HJ, Sohn SK, Min YH, Won JH, Kim I, Yoon HJ, Lee JH, Jo DY, Joo YD, Jung CW, Lee KH; Korean Society of Hematology, AML/MDS Working Party, Chung JS, Ahn JS, Kim SJ, Lee JH, Choi SJ, Lee JH, Bae SH, Hong DS, Zang DY, Kim SH, Lee JL, Bang SM.

Int J Hematol. 2010 Jun;91(5):886-91. doi: 10.1007/s12185-010-0580-2. Epub 2010 May 8.

A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation

Kim ST1¹, Lee MH, Kim SY, Kim SJ, Kim DH, Jang JH, Kim K, Kim WS, Jung CW.

Ann Oncol. 2010 Jun;21(6):1179-88. doi: 10.1093/annonc/mdp452. Epub 2009 Oct 29.

Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy

Kim DH1¹, Xu W, Kamel-Reid S, Liu X, Jung CW, Kim S, Lipton JH.

Leuk Res. 2010 Feb;34(2):166-72. doi: 10.1016/j.leukres.2009.05.009. Epub 2009 Jun 10.

BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients

Moon JH1¹, Sohn SK, Lee MH, Jang JH, Kim K, Jung CW, Kim DH.

J Clin Oncol. 2010 Feb 1;28(4):e54-5. doi: 10.1200/JCO.2009.23.7560. Epub 2009 Nov 16.

Gastric Recurrence of Extramedullary Granulocytic Sarcoma After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Choi ER1¹, Ko YH, Kim SJ, Jang JH, Kim K, Kang WK, Jung CW, Kim DH.

Eur J Haematol. 2010 Feb 1;84(2):154-9. doi: 10.1111/j.1600-0609.2009.01378.x. Epub 2009 Nov 12.

Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia

Chang MH1¹, Kim KH, Kim HS, Jun HJ, Kim DH, Jang JH, Kim K, Jung CW.

Haematologica. 2009 Jan;94(1):135-9. doi: 10.3324/haematol.13151. Epub 2008 Dec 9.

Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia

Kim DH1¹, Kamel-Reid S, Chang H, Sutherland R, Jung CW, Kim HJ, Lee JJ, Lipton JH.

Leuk Lymphoma. 2008 Apr;49(4):700-9. doi: 10.1080/10428190701843247.

Prognostic implications of the immunophenotype in biphenotypic acute leukemia

Lee JH1¹, Min YH, Chung CW, Kim BK, Yoon HJ, Jo DY, Shin HJ, Bang SM, Won JH, Zang DY, Kim HJ, Chi HS, Lee KH, Cheong JW, Kim JS, Kim SH, Park S, Park SY, Chung JS, Lee JH, Park CJ; Korean Society of Hematology AML/MDS Working Party.

Clin Immunol. 2007 Dec;125(3):257-67. Epub 2007 Oct 3.

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma

Kim JH1¹, Lee Y, Bae YS, Kim WS, Kim K, Im HY, Kang WK, Park K, Choi HY, Lee HM, Baek SY, Lee H, Doh H, Kim BM, Kim CY, Jeon C, Jung CW.

J Korean Med Sci. 2007 Aug;22(4):758-61.

A case of deep vein thrombosis and pulmonary thromboembolism after intravenous immunoglobulin therapy

Lee YJ1¹, Shin JU, Lee J, Kim K, Kim WS, Ahn JS, Jung CW, Kang WK.

Bone Marrow Transplant. 2007 Jun;39(11):711-6. Epub 2007 Apr 9.

New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survival

Kim ST1¹, Jung CW, Lee J, Kwon JM, Oh SY, Park BB, Lee HR, Kim HJ, Kim K, Kim WS, Ahn JS, Kang WK, Park K.

Leuk Lymphoma. 2007 May;48(5):937-43.

Postremission therapy for acute myeloid leukemia in the first remission

Kim ST1¹, Jung CW, Lee J, Kwon JM, Oh SY, Park BB, Lee HR, Kim HJ, Kim K, Kim WS, Ahn JS, Kang WK, Park K.

Leuk Lymphoma. 2006 Oct;47(10):2128-31.

High incidence of mucosa-associated lymphoid tissue in primary thyroid lymphoma: A clinicopathologic study of 18 cases in the Korean population

Cho JH1¹, Park YH, Kim WS, Oh SY, Cho SI, Kang HJ, Na II, Ryoo BY, Yang SH, Kim K, Jung CW, Park K, Ko YH, Lee SS.

Ann Hematol. 2006 May;85(5):285-90. Epub 2006 Mar 4.

Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia

Park YH1¹, Kim WS, Kang HJ, Na II, Ryoo BY, Yang SH, Lee SS, Uhm JE, Kim K, Jung CW, Park K, Ko YH.

Cancer Chemother Pharmacol. 2006 Jan;57(1):91-6. Epub 2005 Nov 5.

Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer

Park SH1¹, Lee J, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Park YS, Kang WK, Park K, Kim S, Bang SM, Cho EK, Shin DB, Lee JH.

Oncol Rep. 2005 May;13(5):859-64.

Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma

Kim JH1¹, Jung CW, Cho YH, Lee J, Lee SH, Kim HY, Park J, Park JO, Kim K, Kim WS, Park YS, Im YH, Kang WK, Park K.

J Cell Biochem. 2005 Mar 1;94(4):695-707.

Arsenic trioxide represses constitutive activation of NF-kappa B and COX-2 expression in human acute myeloid leukemia, HL-60

Han SS1¹, Kim K, Hahm ER, Park CH, Kimler BF, Lee SJ, Lee SH, Kim WS, Jung CW, Park K, Kim J, Yoon SS, Lee JH, Park S.

Biol Blood Marrow Transplant. 2005 Feb;11(2):122-8.

Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission

Lee SH1¹, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K.

Cell Signal. 2005 Jan;17(1):111-9.

Activation of Rafl and the ERK pathway in response to L-ascorbic acid in acute myeloid leukemia cells

Park S1¹, Park CH, Hahm ER, Kim K, Kimler BF, Lee SJ, Park HK, Lee SH, Kim WS, Jung CW, Park K, Riordan HD, Lee JH.

J Cell Biochem. 2004 Oct 1;93(2):257-70.

L-ascorbic acid represses constitutive activation of NF-kappa B and COX-2 expression in human acute myeloid leukemia, HL-60

Han SS1¹, Kim K, Hahm ER, Lee SJ, Surh YJ, Park HK, Kim WS, Jung CW, Lee MH, Park K, Yang JH, Yoon SS, Riordan NH, Riordan HD, Kimler BF, Park CH, Lee JH, Park S.

Am J Hematol. 2004 Mar;75(3):121-7.

Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA

Jung CW1¹, Kwon JH, Seol JG, Park WH, Hyun JM, Kim ES, Kim ST, Lee SJ, Kim BK, Lee YY.

Bone Marrow Transplant. 2003 Nov;32(9):889-95.

Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia

Park J1¹, Lee MH, Lee HR, Park SH, Lee SH, Lee KE, Lee H, Park JO, Kim K, Jung CW, Im YH, Kang WK, Ko YH, Park K.

Int J Oncol. 2003 May;22(5):1129-34.

Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis

Park WH1¹, Jung CW, Park JO, Kim K, Kim WS, Im YH, Lee MH, Kang WK, Park K.

Int J Oncol. 2003 Apr;22(4):855-60.

Monensin inhibits the growth of renal cell carcinoma cells via cell cycle arrest or apoptosis

Park WH1¹, Jung CW, Park JO, Kim K, Kim WS, Im YH, Lee MH, Kang WK, Park K.

Int J Oncol. 2003 Feb;22(2):377-82.

Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis

Park WH1¹, Kim ES, Jung CW, Kim BK, Lee YY.

Biochem Biophys Res Commun. 2003 Jan 3;300(1):230-5.

Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis

Hyun Park W1¹, Hee Cho Y, Won Jung C, Oh Park J, Kim K, Hyuck Im Y, Lee MH, Ki Kang W, Park K.

Int J Hematol. 2002 Dec;76(5):465-70.

Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: Multicenter trial

Oh HS1¹, Choi JH, Park CK, Jung CW, Lee SI, Park Q, Suh C, Kim SB, Chi HS, Lee JH, Cho EK, Bang SM, Ahn MJ.

Br J Haematol. 2002 Nov;119(2):400-7.

Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis

Park WH1¹, Seol JG, Kim ES, Kang WK, Im YH, Jung CW, Kim BK, Lee YY.

Int J Hematol. 2001 Dec;74(4):416-20.

Erythropoietin response is inadequate in cancer patients receiving chemotherapy

Lee SJ1¹, Kwon JH, Jung CW.